Prosight Management as of Sept. 30, 2024
Portfolio Holdings for Prosight Management
Prosight Management holds 45 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Adc Therapeutics Sa SHS (ADCT) | 7.5 | $30M | 9.6M | 3.15 | |
| Galapagos Nv Spon Adr (GLPG) | 7.3 | $30M | 1.0M | 28.79 | |
| Bridgebio Pharma (BBIO) | 6.8 | $28M | 1.1M | 25.46 | |
| Abcellera Biologics (ABCL) | 5.8 | $24M | 9.1M | 2.60 | |
| Meiragtx Holdings (MGTX) | 5.0 | $20M | 4.9M | 4.17 | |
| Roivant Sciences SHS (ROIV) | 4.9 | $20M | 1.7M | 11.54 | |
| Shattuck Labs (STTK) | 4.9 | $20M | 5.7M | 3.49 | |
| Mirum Pharmaceuticals (MIRM) | 4.5 | $18M | 466k | 39.00 | |
| Zimmer Holdings (ZBH) | 4.4 | $18M | 166k | 107.95 | |
| McKesson Corporation (MCK) | 4.4 | $18M | 36k | 494.42 | |
| Kura Oncology (KURA) | 3.4 | $14M | 705k | 19.54 | |
| Schrodinger (SDGR) | 3.2 | $13M | 700k | 18.55 | |
| Zymeworks Del (ZYME) | 2.8 | $12M | 918k | 12.55 | |
| Accolade (ACCD) | 2.7 | $11M | 2.8M | 3.85 | |
| Dex (DXCM) | 2.6 | $11M | 160k | 67.04 | |
| Syndax Pharmaceuticals (SNDX) | 2.6 | $11M | 554k | 19.25 | |
| Immunovant (IMVT) | 2.6 | $11M | 370k | 28.51 | |
| Cytokinetics Com New (CYTK) | 2.5 | $10M | 193k | 52.80 | |
| Janux Therapeutics (JANX) | 2.3 | $9.3M | 205k | 45.43 | |
| Prothena Corp SHS (PRTA) | 2.0 | $8.1M | 484k | 16.73 | |
| Neurocrine Biosciences (NBIX) | 1.8 | $7.1M | 62k | 115.22 | |
| Ishares Tr Put Put Option | 1.6 | $6.4M | 29k | 220.89 | |
| Erasca (ERAS) | 1.3 | $5.4M | 2.0M | 2.73 | |
| Haemonetics Corporation (HAE) | 1.3 | $5.2M | 65k | 80.38 | |
| Livanova SHS (LIVN) | 1.2 | $4.7M | 90k | 52.54 | |
| Cogent Biosciences (COGT) | 1.1 | $4.4M | 411k | 10.80 | |
| Cassava Sciences Put Put Option | 1.1 | $4.4M | 149k | 29.43 | |
| Blueprint Medicines (BPMC) | 1.1 | $4.4M | 47k | 92.50 | |
| Tectonic Therapeutic (TECX) | 1.0 | $4.2M | 138k | 30.30 | |
| Cytomx Therapeutics (CTMX) | 0.9 | $3.6M | 3.0M | 1.18 | |
| Sight Sciences (SGHT) | 0.8 | $3.3M | 531k | 6.30 | |
| Viking Therapeutics (VKTX) | 0.7 | $3.0M | 48k | 63.31 | |
| Rocket Pharmaceuticals (RCKT) | 0.7 | $2.9M | 159k | 18.47 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.7 | $2.7M | 130k | 20.63 | |
| Mural Oncology Pub Ord Shs (MURA) | 0.4 | $1.8M | 571k | 3.13 | |
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.4 | $1.7M | 208k | 8.31 | |
| Vincerx Pharma Com New | 0.4 | $1.6M | 2.2M | 0.72 | |
| Aileron Therapeutics Com New (RNTX) | 0.3 | $1.3M | 372k | 3.54 | |
| Corvel Corp Put Put Option | 0.2 | $915k | 2.8k | 326.89 | |
| Select Medical Holdings Corporation (SEM) | 0.2 | $909k | 26k | 34.87 | |
| Ovid Therapeutics (OVID) | 0.2 | $861k | 729k | 1.18 | |
| Immunome (IMNM) | 0.1 | $572k | 39k | 14.62 | |
| Immuneering Corp Class A Com (IMRX) | 0.1 | $473k | 190k | 2.49 | |
| Acadia Healthcare (ACHC) | 0.1 | $359k | 5.7k | 63.41 | |
| Shattuck Labs Put Call Option | 0.1 | $303k | 87k | 3.49 |
